Identification of the kinase STK25 as an upstream activator of LATS signaling
Hippo pathway inactivation plays a role in many cancers, although how tumor cells depress signaling is unclear. Here, Lim et al. identify STK25, which activates LATS in a manner distinct from other upstream kinases and is focally deleted from a range of human cancers.
Guardado en:
Autores principales: | Sanghee Lim, Nicole Hermance, Tenny Mudianto, Hatim M. Mustaly, Ian Paolo Morelos Mauricio, Marc A. Vittoria, Ryan J. Quinton, Brian W. Howell, Hauke Cornils, Amity L. Manning, Neil J. Ganem |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb44cfbe9f3a4df592b8189461124a06 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Fengyuan Tang, et al.
Publicado: (2019) -
Light limitation inducing overcompensatory growth of cyanobacteria and function of serine/threonine kinase (STK) genes involved
por: Wei Dai, et al.
Publicado: (2021) -
Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues
por: Nathaniel Kastan, et al.
Publicado: (2021) -
AIF downregulation and its interaction with STK3 in renal cell carcinoma.
por: Shengqiang Xu, et al.
Publicado: (2014) -
Dziesięć lat „LingVariów”
Publicado: (2015)